Trials / Conditions / Opioid-Induced Bowel Dysfunction
Opioid-Induced Bowel Dysfunction
8 registered clinical trials studyying Opioid-Induced Bowel Dysfunction.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | The Effect of Naldemedine on Opioid-induced Bowel Dysfunction NCT06334198 | Asbjørn Mohr Drewes | Phase 2 |
| Completed | The Influence of Tramadol on Opioid-induced Bowel Dysfunction NCT06385561 | Asbjørn Mohr Drewes | Phase 2 |
| Unknown | The Efficacy of Acupressure in Managing Opioid-induced Constipation NCT04876508 | Istanbul Aydın University | N/A |
| Completed | Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL) NCT01298219 | Sucampo Pharma Americas, LLC | Phase 3 |
| Completed | Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel NCT01122030 | Shionogi | Phase 2 |
| Completed | Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone NCT00620061 | Sucampo Pharma Americas, LLC | Phase 3 |
| Completed | Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone NCT00595946 | Sucampo Pharma Americas, LLC | Phase 3 |
| Completed | Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone NCT00597428 | Sucampo Pharma Americas, LLC | Phase 3 |